Legal Representation
Attorney
Alan M. Doernberg
USPTO Deadlines
Application History
40 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Aug 19, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Aug 19, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Jul 21, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 20, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 19, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 19, 2018 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Jul 19, 2018 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jul 18, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 18, 2018 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 18, 2018 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jan 20, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 18, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 18, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jan 18, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jul 21, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 19, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 19, 2017 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jul 19, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jan 13, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 11, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 11, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jan 11, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jul 19, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 24, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 24, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 4, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 19, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 18, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Apr 18, 2016 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 18, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 18, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Apr 15, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Apr 15, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 15, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 23, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Oct 23, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Oct 23, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Oct 21, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 22, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jul 20, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing an on-line computer database featuring scientific and medical research information in the field of genetics; Research in the fields of science, technology, medicine and health, namely, nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Consultation services in the field of science and technology consultation in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Consulting services in the field of cloud computing in the fields of life science; Consulting services in the fields of bioinformatics, namely, the development of software for understanding biological data; Computer services, namely, providing temporary use of on-line non-downloadable software for accessing and analyzing information in the field of science, technology, medicine, health and public policy; providing online non-downloadable software for the custom design and ordering of assays and reagents; Medical research and laboratory diagnostic services in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Product development for others; Laboratory services, namely, nucleic acid sequencing, synthesis and analysis, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; Laboratory services, namely, nucleic acid analysis; Scientific research in the field of genetics, namely, gene discovery; Scientific research in the field of genetics, namely, genetic diseases, genomics and gene expression research and development; Research on the subject of pharmaceuticals, namely, pharmacokinetics; Scientific research services in the field of proteomics; Genetic testing and mapping services for scientific purposes, namely, gene identification, gene cloning, gene expression, electrophoresis, protein purification and analysis, and protein interaction detection; Medical and scientific research; Medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; Technical research and consultation related thereto in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; Pharmaceutical research services; Providing an on-line searchable database in the field of life science for scientific research purposes; Providing medical and scientific research information in the fields of pharmaceuticals, molecular diagnostics, and genetics; Development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; Medical laboratory services; Research and development for new immunotherapy products for others; Scientific research services; Medical laboratory testing and diagnostic services for others in the fields of science and research related thereto; Scientific research, namely, developing customized microbiological, mammalian, and insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; Contract medical laboratory services, namely, conducting drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, namely, enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and p-glycloprotein assays; Consulting services in the field of contract medical laboratory services, namely, conducting drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, namely, enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and p-glycloprotein assays; Electronic storage of data, graphs, images and information in the fields of cloud computing, life science, medical research, scientific research and clinical research
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042